Stent with polymer coating containing amorphous rapamycin
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 17, 2020
Grant Date -
Jan 21, 2016
app pub date -
May 21, 2015
filing date -
Jul 15, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
A coated coronary stent, comprising a stainless steel sent framework coated with a primer layer of Parylene C, and a rapamycin-polymer coating having substantially uniform thickness disposed on the stent framework, wherein the rapamycin-polymer coating comprises polybutyl methacrylate (PBMA), polyethylene-co-vinyl acetate (PEVA) and rapamycin, wherein substantially all of the rapamycin in the coating is in amorphous form and substantially uniformly dispersed within the rapamycin-polymer coating.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2015 Application Filing Year
- A61F Class
- 5839 Applications Filed
- 4516 Patents Issued To-Date
- 77.35 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- A61F Class
- 0 % this patent is cited more than
- 5 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | May 17, 2028 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | May 17, 2032 |
